The COVID-19 pandemic has brought into question how we approach care across multiple disease areas in the future. But what does this mean in cancer? Hear from Bristol Myers Squibb’s (BMS) Executive Medical Director, Hubert Bland, who believes that in order to advance in cancer care, we must learn from the COVID-19 response and adopt a collaborative approach across the healthcare industry.
Read More
To deliver high standards of support to healthcare professionals we have to be both digitally-savvy and relationship-smart
Read More
Dr Jason Raw outlines key findings from the SYNPASES trial, which explored the tolerability of safinamide used as an adjunct therapy in patients with Parkinson’s disease
Read More
The global COVID pandemic has highlighted the need for expert leadership in global healthcare. Oxford University is rising to the challenge, pulling together specialists from business and medical departments to launch an MSc in Global Healthcare Leadership
Read More
Ipsen Pharmaceuticals’ Global Digital Health Partnerships Lead, Dr Myles Furnace, discusses the company’s new partnership with digital health specialists Mendelian, which aims to improve the speed of diagnosis of rare diseases
Read More
